The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: INFLIXIMAB, RECOMBINANT     Injury: Foetal exposure during pregnancy     Quarter: 2016Q3

  |<   1/2   << Previous Page   Page 1  

Total Records: 7     Number of Pages: 1

Event ID DRUGNAME PT Drug Manufacturer Patient Age Sex Weight Date (YYYYMMDD) Country
125532811 INFLIXIMAB, RECOMBINANT Foetal exposure during pregnancy JANSSEN 0.00 0 20160713 DK
125576431 INFLIXIMAB, RECOMBINANT Foetal exposure during pregnancy JANSSEN 0.00 0 20160714 DK
127212751 INFLIXIMAB, RECOMBINANT Foetal exposure during pregnancy JANSSEN 0.00 0 20160907 NL
127212771 INFLIXIMAB, RECOMBINANT Foetal exposure during pregnancy JANSSEN 0.00 0 20160907 NL
127212781 INFLIXIMAB, RECOMBINANT Foetal exposure during pregnancy JANSSEN 0.00 0 20160907 NL
127212791 INFLIXIMAB, RECOMBINANT Foetal exposure during pregnancy JANSSEN 0.00 0 20160907 NL
127261981 INFLIXIMAB, RECOMBINANT Foetal exposure during pregnancy JANSSEN 0.00 0 20160908 NL

  |<   1/2   << Previous Page   Page 1  

Total Records: 7     Number of Pages: 1

Execution Time: 0.017442941665649 seconds (ucode:5188338). Developed by: James D. Barger

 


another James Barger innovation
All original content on this site is © 2013-2024 James D. Barger and SafetyRates.com.